Skip to content

Redeemable NCI at other companies

Select Medical Holdings logo
Select Medical HoldingsSEM
$20.97M+132%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$58.8M+4.8%
Tenet Healthcare logo
Tenet HealthcareTHC
$2.14B-23.0%
Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
$21.76M+16.9%

Other financials

Income statement

See full
Revenue$198.3M+7.9%
Gross profit$32.8M+5.4%
Operating income$12.5M-36.5%
Net income$5.0M-49.1%
EPS (diluted)-$0.12-115%

Balance sheet

See full
Cash & equivalents$28.4M-27.4%
Total debt$169.4M+12.6%
Total equity$469.0M-5.7%
Total assets$1.2B+5.3%

Cash flow

See full
Operating cash flow$3.8M+181%
CapEx$5.4M+108%
Free cash flow-$1.6M+78.4%

Valuation

See full
Market cap$1.01B-10.6%
Enterprise value$1.15B-7.2%
P/E29×-4.8×
P/S1.3×-0.3×

Profitability

See full
Gross margin19%+0.9pp
Operating margin10%+0.3pp
Net margin4.4%-0.4pp
FCF margin8.4%+0.4pp

Returns & leverage

See full
Return on equity7.2%+0.4pp
Debt / equity0.4×+0.1×
Current ratio1.2×0.0×

Where this comes from

Reported directly by US Physical Therapy in its filing.

Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.

The official record: US Physical Therapy’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about US Physical Therapy's redeemable nci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is US Physical Therapy's redeemable NCI?
US Physical Therapy (USPH) reported redeemable NCI of $313.44M in Q1 2026.
How has US Physical Therapy's redeemable NCI changed year-over-year?
US Physical Therapy's redeemable NCI increased by 20.5% year-over-year, from $260.05M to $313.44M.
What is the long-term trend for US Physical Therapy's redeemable NCI?
Over 5 years (2020 to 2025), US Physical Therapy's redeemable NCI has grown at a 17.3% compound annual growth rate (CAGR), from $132.34M to $293.31M.
What does redeemable NCI mean?
Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.